Gene · 406936
Papers3,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. | Cancers (Basel) | 2023 | 37958352 | PubTator, text mining | PubMed |
| Evaluation of miR-let-7f, miR-125a, and miR-125b expression levels in sputum and serum samples of Iranians and Afghans with pulmonary tuberculosis. | Iran J Microbiol | 2023 | 37941875 | PubTator, text mining | PubMed |
| Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer. | Technol Cancer Res Treat | 2023 | 37936417 | PubTator, text mining | PubMed |
| Longitudinal dynamics of circulating miRNAs in a swine model of familial hypercholesterolemia during early atherosclerosis. | Sci Rep | 2023 | 37935844 | PubTator, text mining | PubMed |
| Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer. | Sci Rep | 2023 | 37935712 | PubTator, text mining | PubMed |
| SRY-box transcription factor 21 antisense divergent transcript 1: Regulatory roles and clinical significance in neoplastic conditions and Alzheimer's Disease. | J Cancer | 2023 | 37928430 | PubTator, text mining | PubMed |
| High Expression of NRF2 and Low Expression of KEAP1 Predict Worse Survival in Patients With Operable Triple-Negative Breast Cancer. | J Breast Cancer | 2023 | 37926068 | PubTator, text mining | PubMed |
| Integration of circulating microRNAs and transcriptome signatures identifies early-pregnancy biomarkers of preeclampsia. | Clin Transl Med | 2023 | 37905457 | PubTator, text mining | PubMed |
| The Role of ncRNAs in the Immune Dysregulation of Preeclampsia. | Int J Mol Sci | 2023 | 37894897 | PubTator, text mining | PubMed |
| mTORC1 and SGLT2 Inhibitors-A Therapeutic Perspective for Diabetic Cardiomyopathy. | Int J Mol Sci | 2023 | 37894760 | PubTator, text mining | PubMed |
| MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets. | Cancers (Basel) | 2023 | 37894390 | PubTator, text mining | PubMed |
| Panoramic on Epigenetics in Coronary Artery Disease and the Approach of Personalized Medicine. | Biomedicines | 2023 | 37893238 | PubTator, text mining | PubMed |
| Comparative analysis between 2D and 3D colorectal cancer culture models for insights into cellular morphological and transcriptomic variations. | Sci Rep | 2023 | 37884554 | PubTator, text mining | PubMed |
| Integrative bioinformatics analysis to screen key genes and signalling pathways related to ferroptosis in obesity. | Adipocyte | 2023 | 37878496 | PubTator, text mining | PubMed |
| A plasma miRNA-based classifier for small cell lung cancer diagnosis. | Front Oncol | 2023 | 37869089 | PubTator, text mining | PubMed |
| Methods of miRNA delivery and possibilities of their application in neuro-oncology. | Noncoding RNA Res | 2023 | 37860265 | PubTator, text mining | PubMed |
| Highly expressed miR-144-3p promotes the proliferation, migration and invasion of colon carcinoma cells by activating the Wnt/β-catenin signaling pathway through targeting SFRP1. | J Cancer | 2023 | 37859826 | PubTator, text mining | PubMed |
| Nuclear lncRNA NORSF reduces E2 release in granulosa cells by sponging the endogenous small activating RNA miR-339. | BMC Biol | 2023 | 37858148 | PubTator, text mining | PubMed |
| Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma. | J Oral Maxillofac Pathol | 2023 | 37854932 | PubTator, text mining | PubMed |
| Lipid metabolism as a target for cancer drug resistance: progress and prospects. | Front Pharmacol | 2023 | 37841917 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406936/papers?page=8